Qsymia (phentermine/topiramate) for weight loss: honest guide
Qsymia is a US FDA-approved weight-loss pill that combines two medicines, phentermine (an appetite suppressant) and topiramate (an anticonvulsant that also cuts appetite). In trials it helped people lose about 8 to 10 percent of body weight over a year at the top dose, but it carries real risks, especially birth defects if taken in pregnancy. It is not approved or marketed in India as the single combo pill, so an Indian reader must ask their doctor and avoid pregnancy carefully.
13 Jul 2026 · Burnie Academy
qsymiaphenterminetopiramateweight-loss-medicine
Qsymia is a prescription weight-loss pill used in the United States. It is not a single new medicine but a fixed combination of two older medicines, phentermine and topiramate, put into one extended-release capsule. It is approved by the US Food and Drug Administration (FDA) for people with obesity or with overweight plus a weight-related health problem. It can help, and in the main trials people lost about 8 to 10 percent of body weight over a year at the top dose. But Qsymia is not a light medicine. It can cause birth defects if taken in pregnancy, it can affect mood and thinking, and it has a list of other serious risks. It is also not approved or sold as the combo pill in India. This guide gives you the honest picture so you can talk to your doctor with the right facts.
CONTINUE READING FOR FREE
Unlock the complete article
Register with just your mobile number and OTP. No password and no payment.
📱Use this same phone number in the Burnie mobile app. Your profile, liked articles and favourites will stay synced.
